Only three cycles of nivolumab showed remarkable durable response and reversible myeloradiculoneuropathy in a patient with metastatic papillary renal cell carcinoma type 2

INTRODUCTION: The efficacy of nivolumab for non‐clear cell renal cell carcinoma is still unclear. We present a rare case of metastatic papillary renal cell carcinoma remarkably responded to nivolumab but developed myeloradiculoneuropathy as immune‐related adverse event. CASE PRESENTATION: The patien...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:IJU Case Rep
Hlavní autoři: Iwasaki, Kazunori, Shin, Toshitaka, Inoue, Toru, Shibuya, Tadamasa, Hirai, Kenichi, Ando, Tadasuke, Mimata, Hiromitsu
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2021
Témata:
Case Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088879/
https://ncbi.nlm.nih.gov/pubmed/33977240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12262
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky